Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chalcone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102344351B reveals a novel biaryl chalcone synthesis with V-shaped conformation for superior antitumor activity. Discover scalable routes and cost-effective manufacturing strategies.
Novel synthesis of 4'-hydroxy-4,6'-dimethoxydihydrochalcone via Pd/C hydrogenation offers high purity and scalable pharmaceutical intermediate production.
Novel synthesis of licochalcone A dihydropyrazole derivatives. Mild conditions, scalable process for pharmaceutical intermediates. Reliable supply chain partner for global drug development.
Patent CN107235917A details a mild synthesis of licochalcone A dihydropyrimidines. Enhances solubility and antitumor activity for reliable pharmaceutical intermediate supply.
Patent CN107311953A details a mild synthesis of antitumor dihydroisoxazole licochalcone A. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel antitumor derivative synthesis offers mild conditions and high safety for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN105037072B reveals metal-free synthesis for high-purity 1,3,5-triarylbenzenes, offering cost reduction and supply chain reliability for electronic chemical manufacturing.
Patent CN109081856B reveals a high-yield route for 4-ferrocenyl-6-aryl-2-aminopyrimidines, offering cost reduction in API manufacturing and scalable production capabilities.
Novel non-hydrogenation route for 2'-hydroxydihydrochalcone using 2-phenyl-benzothiazoline. Safe, scalable, cost-effective API intermediate manufacturing.
Patent CN107382640A reveals a selenium-catalyzed reduction method for β-arylpropiophenones. Offers high purity, cost efficiency, and scalable supply chain solutions for global buyers.
Patent CN111925282A reveals mild catalytic reduction for high-purity pharmaceutical intermediates. Enhances supply chain safety and reduces manufacturing costs significantly.
Patent CN114456086B details green synthesis of beta-cyano ketone using acetone cyanohydrin. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel antitumor derivative synthesis via mild ethanol reflux. Enhances solubility and activity. Reliable supply chain partner for pharmaceutical intermediates.
Novel green synthesis of beta-cyano ketones using acetone cyanohydrin. High yield, low toxicity, scalable process for pharmaceutical intermediates.
Patent CN107032972B details a catalytic asymmetric Diels-Alder route for flavonoid intermediates, offering high enantioselectivity and simplified purification for pharmaceutical manufacturing.
Novel Pd-catalyzed carbonylation method for alpha,beta-unsaturated carbonyls. High yield, mild conditions, scalable for pharmaceutical supply chains.
Patent CN110423215B reveals a novel chalcone pyridinium salt synthesis enabling efficient nitrogen-bridged ring construction with mild conditions and high purity.
Patent CN107235902A details a mild synthesis route for antitumor licochalcone A derivatives, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel one-pot synthesis of spiroisoxazolines from dihydrochalcones. High yield, mild conditions, cost-effective pharmaceutical intermediate manufacturing.
Discover how iodine-catalyzed synthesis of imidazo[1,2-a]pyridine achieves 86% yield, eliminates heavy metals, and reduces purification costs for pharmaceutical intermediates.